LeukoDx presented at the Philapdelphia Angel Fair on April 13th, 2011
On April 11th, 2011 LeukoDx signed aTerm Sheet with American investors for a potential investment of $5 million in three tranches
LeukoDx presented at the 'OneMedForum' on January 12, 2010 in San Francisco, CA. The 'OneMedForum' was established as an annual event by OneMedPlace "to connect emerging healthcare and life science companies with investors and strategic partners. Over 100 company presentations will occur by some of the most promising companies in the world." This will be another valuable opportunity to bring attention to LeukoDx and its potential as a leading point of care diagnostic company.
Back to top
LeukoDx Chosen as Finalists in the Life Science Accelerator (LSA) Start-up Competition 2009
LeukoDx was chosen as one of 10 companies to be a finalist in the LSA's Start-up Competition 2009. Julien Meissonnier, LeukoDx President and CEO, presented to the judging panel on December 16, 2009. LSA is a leading accelerator and opinion leader in Israel's life science and medical device industries.
LeukoDx Presents at the 'Life Sciences and Healthcare Venture Summit' in New York
Julien Meissonnier, President and CEO of LeukoDx, presented at the 'Life Sciences and Healthcare Venture Summit' on October 27, 2009 in New York, NY. Mr. Meissonnier presented LeukoDx's innovative point of care flow cytometry technology platform to leading venture capitalists, angel investors and investment firms focused on the Healthcare IT, Life Sciences and Healthcare sectors. It was a valuable and beneficial networking and showcase opportunity.
LeukoDx receives approval for grant for 50% of $600K R&D budget from the Israeli Office of the Chief Scientist.
LeukoDx closes angel seed funding - July 2009.